AKT1 and cancer: Furthermore, KEGG enrichment analysis revealed that these ARGs are involved in platinum drug resistance, transcriptional dysregulation in cancer, and some oncogenic pathways such as MAPK, P53, TNF, and PI3K-AKT signaling pathways (Fig. 2c).